학술논문

203P Clinical effectiveness of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer (mBC) by ER expression level: Subgroup analysis from phase IIIb LUCY trial
Document Type
Abstract
Source
In ESMO Open May 2023 8(1) Supplement 4
Subject
Language
ISSN
2059-7029